$117 Million is the total value of Samjo Capital LLC's 18 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was - .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
QUOT | New | QUOTIENT TECHNOLOGY INC | $23,409,000 | – | 2,485,000 | +100.0% | 19.97% | – |
PDFS | New | PDF SOLUTIONS INC | $22,032,000 | – | 1,020,000 | +100.0% | 18.79% | – |
GAN | New | GAN LTD | $13,182,000 | – | 650,000 | +100.0% | 11.24% | – |
INOV | New | INOVALON HLDGS INC | $8,358,000 | – | 460,000 | +100.0% | 7.13% | – |
VG | New | VONAGE HLDGS CORP | $8,240,000 | – | 640,000 | +100.0% | 7.03% | – |
GNMK | New | GENMARK DIAGNOSTICS INC | $7,738,000 | – | 530,000 | +100.0% | 6.60% | – |
ASPN | New | ASPEN AEROGELS INC | $7,221,000 | – | 432,657 | +100.0% | 6.16% | – |
ITI | New | ITERIS INC NEW | $7,147,000 | – | 1,265,000 | +100.0% | 6.10% | – |
NEPH | New | NEPHROS INC | $4,719,000 | – | 550,000 | +100.0% | 4.02% | – |
NEO | New | NEOGENOMICS INC | $3,769,000 | – | 70,000 | +100.0% | 3.22% | – |
RSSS | New | RESEARCH SOLUTIONS INC | $1,864,000 | – | 800,000 | +100.0% | 1.59% | – |
HTGM | New | HTG MOLECULAR DIAGNOSTICS IN | $1,828,000 | – | 381,713 | +100.0% | 1.56% | – |
FRG | New | FRANCHISE GROUP INC | $1,827,000 | – | 60,000 | +100.0% | 1.56% | – |
New | ACCELERATE DIAGNOSTICS INCnote 2.500% 3/1 | $1,465,000 | – | 2,600,000 | +100.0% | 1.25% | – | |
THRY | New | THRYV HLDGS INC | $1,350,000 | – | 100,000 | +100.0% | 1.15% | – |
DMRC | New | DIGIMARC CORP NEW | $1,181,000 | – | 25,000 | +100.0% | 1.01% | – |
SHSP | New | SHARPSPRING INC | $993,000 | – | 61,000 | +100.0% | 0.85% | – |
TACT | New | TRANSACT TECHNOLOGIES INC | $923,000 | – | 130,000 | +100.0% | 0.79% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-11
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
PDF SOLUTIONS INC | 12 | Q3 2023 | 30.2% |
THRYV HLDGS INC | 12 | Q3 2023 | 15.9% |
ASPEN AEROGELS INC | 12 | Q3 2023 | 11.8% |
ITERIS INC NEW | 12 | Q3 2023 | 14.0% |
DIGIMARC CORP NEW | 12 | Q3 2023 | 1.3% |
SOCIETAL CDMO INC | 11 | Q3 2023 | 6.4% |
COMSCORE INC | 11 | Q3 2023 | 6.3% |
QUOTIENT TECHNOLOGY INC | 10 | Q2 2023 | 29.1% |
INSPIRED ENTMT INC | 10 | Q3 2023 | 11.0% |
FRANCHISE GROUP INC | 10 | Q1 2023 | 4.0% |
View Samjo Capital LLC's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HTG MOLECULAR DIAGNOSTICS, INCSold out | February 10, 2023 | 0 | 0.0% |
ITERIS, INC. | February 10, 2023 | 3,280,000 | 7.7% |
Societal CDMO, Inc. | February 10, 2023 | 4,050,000 | 4.8% |
NEPHROS INC | February 08, 2022 | 425,000 | 4.2% |
Research Solutions, Inc. | February 08, 2022 | 1,280,000 | 4.8% |
HTG MOLECULAR DIAGNOSTICS, INC | February 11, 2021 | 381,713 | 8.1% |
NEPHROS INC | October 21, 2020 | 550,000 | 5.6% |
ARI NETWORK SERVICES INC /WI | February 10, 2017 | 941,800 | 5.4% |
Digimarc CORP | February 12, 2016 | 380,200 | 4.3% |
PRGX GLOBAL, INC. | February 09, 2015 | 1,175,000 | 4.3% |
View Samjo Capital LLC's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-NT | 2024-02-09 |
13F-HR | 2023-11-14 |
13F-HR | 2023-08-09 |
13F-HR | 2023-05-10 |
SC 13G/A | 2023-02-10 |
SC 13G/A | 2023-02-10 |
SC 13G/A | 2023-02-10 |
13F-HR | 2023-02-08 |
13F-HR | 2022-11-07 |
13F-HR | 2022-08-04 |
View Samjo Capital LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.